InvestorsHub Logo
Followers 74
Posts 5640
Boards Moderated 0
Alias Born 07/09/2003

Re: stervc post# 674

Sunday, 08/16/2009 5:42:33 PM

Sunday, August 16, 2009 5:42:33 PM

Post# of 5204
Stervc,

That comparison with the figures for NEPH is illuminating.

There was very clear positive differentiation in the ASCO report between Cobroxin and Ultram.

alj
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.